236 related articles for article (PubMed ID: 25281026)
1. Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study.
Roma AA; Masand RP
Hum Pathol; 2014 Dec; 45(12):2417-22. PubMed ID: 25281026
[TBL] [Abstract][Full Text] [Related]
2. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor.
Roma AA; Masand RP
Ann Diagn Pathol; 2015 Feb; 19(1):29-32. PubMed ID: 25596159
[TBL] [Abstract][Full Text] [Related]
3. Vaginal Brenner tumor with literature review: does this tumour originate from Walthard nests?
Park S; Cho MS
Malays J Pathol; 2017 Apr; 39(1):89-93. PubMed ID: 28413211
[TBL] [Abstract][Full Text] [Related]
4. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.
Kuhn E; Ayhan A; Shih IeM; Seidman JD; Kurman RJ
Eur J Cancer; 2013 Dec; 49(18):3839-49. PubMed ID: 24012099
[TBL] [Abstract][Full Text] [Related]
6. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors.
Seidman JD; Khedmati F
Arch Pathol Lab Med; 2008 Nov; 132(11):1753-60. PubMed ID: 18976011
[TBL] [Abstract][Full Text] [Related]
7. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
[TBL] [Abstract][Full Text] [Related]
9. FOXA1 is expressed in ovarian mucinous neoplasms.
Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
[TBL] [Abstract][Full Text] [Related]
10. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
Tong GX; Memeo L; Colarossi C; Hamele-Bena D; Magi-Galluzzi C; Zhou M; Lagana SM; Harik L; Oliver-Krasinski JM; Mansukhani M; Falcone L; Hibshoosh H; O'Toole K
Am J Surg Pathol; 2011 Oct; 35(10):1473-83. PubMed ID: 21934480
[TBL] [Abstract][Full Text] [Related]
11. [Brenner tumor of the ovary--a clinicopathological report of 5 cases].
Li AY; Li XL; Xing LY
Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):218-220, 10. PubMed ID: 3447865
[TBL] [Abstract][Full Text] [Related]
12. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract.
Ogawa K; Johansson SL; Cohen SM
Am J Pathol; 1999 Oct; 155(4):1047-50. PubMed ID: 10514386
[TBL] [Abstract][Full Text] [Related]
14. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
15. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
[TBL] [Abstract][Full Text] [Related]
16. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors.
Kondi-Pafiti A; Kairi-Vassilatou E; Iavazzo Ch; Vouza E; Mavrigiannaki P; Kleanthis Ch; Vlahodimitropoulos D; Liapis A
Arch Gynecol Obstet; 2012 Jun; 285(6):1699-702. PubMed ID: 22198845
[TBL] [Abstract][Full Text] [Related]
18. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
[TBL] [Abstract][Full Text] [Related]
19. Expression of GATA-3 in Testicular and Gynecologic Mesothelial Neoplastic and Non-neoplastic Tissues.
Ronaghy A; Xiao GQ; Santagada E; Hasanovic A; Unger P
Int J Gynecol Pathol; 2018 May; 37(3):284-289. PubMed ID: 28582342
[TBL] [Abstract][Full Text] [Related]
20. Brenner tumors and Walthard cell nests.
Bransilver BR; Ferenczy A; Richart RM
Arch Pathol; 1974 Aug; 98(2):76-86. PubMed ID: 4366206
[No Abstract] [Full Text] [Related]
[Next] [New Search]